Literature DB >> 1786146

Lack of HIV-1 V3 region sequence diversity in two haemophiliac patients infected with a putative biologic clone of HIV-1.

K Cichutek1, S Norley, R Linde, W Kreuz, M Gahr, J Löwer, G von Wangenheim, R Kurth.   

Abstract

Peripheral blood mononuclear cells (PBMC) from two haemophilia B patients, who presumably became infected with a putative HIV-1 biological clone following treatment with the same suspected batch of commercial factor, were used to clone and sequence the hypervariable V3 region of the HIV-1 envelope protein. In 10 of 12 clones the V3 region was identical and two (one from each patient) had a single non-synonymous point mutation. Viable reisolates (shown to be authentic by sequencing of V3) currently appear to be monocyte tropic. These results strongly indicate that the patients were infected from a common source with a very low number of infectious particles and indicate that variability under these conditions is limited.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1786146     DOI: 10.1097/00002030-199110000-00005

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  11 in total

1.  Host-specific driving force in human immunodeficiency virus type 1 evolution in vivo.

Authors:  L Zhang; R S Diaz; D D Ho; J W Mosley; M P Busch; A Mayer
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus.

Authors:  M T Flaherty; D A Hauer; J L Mankowski; M C Zink; J E Clements
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Positive selection and rates of evolution in immunodeficiency viruses from humans and chimpanzees.

Authors:  D P Mindell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

4.  Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV.

Authors:  M C Zink; A M Amedee; J L Mankowski; L Craig; P Didier; D L Carter; A Muñoz; M Murphey-Corb; J E Clements
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

5.  Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus.

Authors:  J E Clements; R C Montelaro; M C Zink; A M Amedee; S Miller; A M Trichel; B Jagerski; D Hauer; L N Martin; R P Bohm
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

6.  Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection.

Authors:  L Q Zhang; P MacKenzie; A Cleland; E C Holmes; A J Brown; P Simmonds
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

8.  Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1.

Authors:  L Zhang; T He; Y Huang; Z Chen; Y Guo; S Wu; K J Kunstman; R C Brown; J P Phair; A U Neumann; D D Ho; S M Wolinsky
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

9.  Development of a quasispecies of human immunodeficiency virus type 1 in vivo.

Authors:  K Cichutek; H Merget; S Norley; R Linde; W Kreuz; M Gahr; R Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

10.  Compartmentalization of surface envelope glycoprotein of human immunodeficiency virus type 1 during acute and chronic infection.

Authors:  Linqi Zhang; Leslie Rowe; Tian He; Chris Chung; Jian Yu; Wenjie Yu; Andrew Talal; Marty Markowitz; David D Ho
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.